Moreover, using focused drug screens, we identified that the BCL-2/Bcl-xL inhibitor ABT-737 was an effective inducer of apoptosis when combined with AZ’1569 in the panel of KRASG12CMT colorectal cancer cells. The gene discussed is BCL2L1; the disease is colorectal cancer.